Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04842097
Other study ID # CRIR-1499-1120/multi
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 16, 2021
Est. completion date January 24, 2022

Study information

Verified date September 2022
Source Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this project is to explore the feasibility and the efficacy of a online mindfulness-based stress reduction intervention for people with chronic pain waiting for secondary or tertiary health care services


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date January 24, 2022
Est. primary completion date December 20, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria: - Men and women aged 18-85 - Self-reported diagnosis of chronic non-cancer pain - Chronic non-cancer pain duration of 3 months or more - Chronic non-cancer pain experienced during 4 days or more per week - Average pain intensity of 4 or more out of 10 in the last seven days - French or English fluency - Access to Wi-Fi - Be able to attend a weekly two-hour MBSR virtual session for eight consecutive weeks Exclusion Criteria: - Cancer-related chronic pain - Currently receiving or have received in the last 24 months coordinated care in pain clinics, hospitals or rehabilitation centers. - Current or recent participation (in the last 12 months and more than 12 sessions) of cognitive-behavioral therapy or MBSR program - Having an unstable psychological conditions such as depression, bipolar disorder, post-traumatic stress disorder, psychotic disorder

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Mindfulness-based stress reduction
An online mindfulness-based stress reduction intervention will be administered in a group format of maximum 15 participants, once a week for 120 minutes for 8 weeks by an experienced therapist trained in MBSR. Sessions will include sitting and lying meditation, hatha yoga and a body scan where attention is sequentially focused on different parts of the body. Individual autonomous practice between 30-45 minutes, 6 times / week will also be recommended. To support individual autonomous practice, a daily diary and two guided videos (around 35 minutes/each) were created.

Locations

Country Name City State
Canada Association québécoise de la douleur chronique Montreal Quebec
Canada Centre de réadaptation Layton-Lethbridge-Mackay Montreal Quebec
Canada Hôpital de Verdun Montreal Quebec

Sponsors (1)

Lead Sponsor Collaborator
Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Participants retention rate The percentage of participants who have completed the 8 online MBSR sessions 2 months
Primary Participants participation rate The percentage of participants on waiting lists who agreed to participate in the intervention 12 months
Secondary Patient-Reported Outcomes Measurement Information System Global-10 Change in domains of health and functioning as measured by the PROMIS Global-10, score range is 7-35 with increases in scores meaning better outcome Change from week start of MBSR intervention (week 0) to end of intervention (week 8), 3-month follow-up (week 21)
Secondary Patient-Reported Outcomes Measurement Information System 29 Change in 8 health-related quality of life domains as measured by the PROMIS 29. PROMIS-29 is a generic patient reported outcome measure, which includes four items from each of the seven PROMIS domains (physical function, depression, anxiety, fatigue, sleep disturbance, and ability to participate in social roles and activities, pain interference) and a single item on pain intensity. Each item has five response options (values 1 to 5), except for the pain intensity item which has eleven response options (values 0 to 10). A total raw score is computed for each domain as the sum of the response to each question within the domain, leading to seven domain scores, each from 4 to 20. Change from week start of MBSR intervention (week 0) to end of intervention (week 8), 3-month follow-up (week 21)
Secondary French-Canadian Chronic Pain Self-Efficacy Scale The French-Canadian Chronic Pain Self-Efficacy Scale (Lacasse et al., 2015) is a 6-item scale that measures an individual's confidence in his/her ability to manage chronic pain in general and pain-related symptoms. Items are rated on a 10-point Likert scale ranging from 1 = not at all confident to 10 = entirely confident. Score range is 6-60 with higher scores reflecting greater chronic pain self-efficacy. Change from week start of MBSR intervention (week 0) to end of intervention (week 8), 3-month follow-up (week 21)
Secondary Chronic Pain Acceptance Questionnaire The Chronic Pain Acceptance Questionnaire (CPAQ-8; Fish et al., 2010 ) is an 8-item scale comprised of two subscales: activity engagement and pain willingness. Items are scored on a 7-point Likert scale ranging from 0 = never true to 6 = always true. Score range is 0-48 with increases in scores meaning better outcome. Change from week start of MBSR intervention (week 0) to end of intervention (week 8), 3-month follow-up (week 21)
Secondary Global Rating of Change Scale The Global Change Rating Scale (11-point visual analogue scale raging from minus 5 to plus 5) will be used to assess the participants' perception of improvement (or decline) in relation to their self-efficacy in manging pain at the end of the MBSR intervention. 3-month follow-up (week 21)
Secondary Pain Catastrophizing Scale Change in pain catastrophizing as measured by the Pain Catastrophizing Scale (French Canadian version). PCS is a 13-item measure using a 5-point Likert scale (0=not at all, 4=all the time) with score range between 0-52 with decreases in scores meaning better outcome. Change from week start of MBSR intervention (week 0) to end of intervention (week 8), 3-month follow-up (week 21)
Secondary Pain Disability Index Change in pain disability as measured by the The French-Canadian Pain Disability Index (score range is 0-70 with decreases in scores meaning better outcome) Change from week start of MBSR intervention (week 0) to end of intervention (week 8), 3-month follow-up (week 21)
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain